Clean Room and GMP Quiz
Test your GMP knowledge by taking a PIC/S GMP Quiz:
How familiar are you with the common concepts of PIC/S GMP?
If you feel you are up to the challenge, test your knowledge by taking the GMP Quiz Master challenge, if you are brave enough, login and leave your details, or you can do the test anonymously.
Feel like a little competitive fun? Why not throw down the gauntlet to friends and colleagues to top your score. Share your score on social media, and let the challenge begin.
PIC/S GMP Quiz 2022
Quiz-summary
0 of 15 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Information
Test your GMP knowledge with the 2022 version of the GMP quiz. There are 15 multiple choice questions, and the quiz will take about 5 minutes to complete.
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Results
0 of 15 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 points, (0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Answered
- Review
-
Question 1 of 15
1. Question
Quality Management is a wide-ranging concept which covers matters which individually or collectively influence the quality of a product.
Correct
GMP reference is PE 009-15, Part I, Chapter 1, Pharmaceutical Quality System, clause 1.1 “Quality Management is a wide-ranging concept, which covers all matters, which individually or collectively influence the quality of a product. It is the sum total of the organised arrangements made with the objective of ensuring that medicinal products are of the quality required for their intended use. Quality Management therefore incorporates Good Manufacturing Practice.”
Incorrect
Incorrect
-
Question 2 of 15
2. Question
GMP applies to the lifecycle stages, from the:
Correct
Incorrect
GMP reference is PE 009-15, Part I, Chapter 1, Pharmaceutical Quality System, clause 1.2 “GMP applies to the lifecycle stages from the manufacture of investigational medicinal products, technology transfer, commercial manufacturing through to product discontinuation. However the Pharmaceutical Quality System can extend to the pharmaceutical development lifecycle stage as described in ICH Q10, which while optional, should facilitate innovation and continual improvement and strengthen the link between pharmaceutical development and manufacturing activities.”
-
Question 3 of 15
3. Question
Who must ensure that each batch of medicinal products has been manufactured and checked in compliance with the laws in force in that country and in accordance with the requirements of the Marketing Authorisation?
The responsibilities of an Authorise Person may be delegated but only to:Correct
MP reference is PE 009-15, Part I, Chapter 2, Personnel, clause 2.6 “The duties of the Authorised Person(s) are described in the national requirements and can be summarised as follows:
- An Authorised Person must ensure that each batch of medicinal products has been manufactured and checked in compliance with the laws in force in that country and in accordance with the requirements of the Marketing Authorisation.”
Incorrect
Incorrect
-
Question 4 of 15
4. Question
Personal medication in the production area should be:
Correct
GMP reference is PE 009-15, Part I, Chapter 2, Personnel, clause 2.19 “Eating, drinking, or smoking, or the storage of food, drink, smoking materials or personal medication in the production and storage areas should be prohibited. In general, any unhygienic practice within the manufacturing areas or any other area where the product might be adversely affected should be forbidden.”
Incorrect
Incorrect
-
Question 5 of 15
5. Question
Quality Risk Management principles should be used to assess and control the risks of cross-contamination.
Correct
GMP reference is PE 009-15, Part I, Chapter 3, Premises and Equipment, clause 3.6 “Cross-contamination should be prevented for all products by appropriate design and operation of manufacturing facilities. The measures to prevent cross-contamination should be commensurate with the risks. Quality Risk Management principles should be used to assess and control the risks.”
Incorrect
Incorrect
-
Question 6 of 15
6. Question
What is the purpose of a protocol?
Correct
GMP reference is PE 009-15, Part I, Chapter 4, Documentation, “Required GMP Documentation (by Type)” section “Protocols: Give instructions for performing and recording certain discreet operations.”
Incorrect
Incorrect
-
Question 7 of 15
7. Question
Incoming materials and finished goods should be:
Correct
GMP reference is PE 009-15, Part I, Chapter 5, Production, clause 5.5 “Incoming materials and finished products should be physically or administratively quarantined immediately after receipt or processing, until they have been released for use or distribution.”
Incorrect
-
Question 8 of 15
8. Question
All the in-process controls, including those made in the production area by production personnel should be performed according to methods approved by:
Correct
GMP reference is PE 009-15, Part I, Chapter 6, Quality Control, clause 6.18 “All the in-process controls, including those made in the production area by production personnel, should be performed according to methods approved by Quality Control and the results recorded.”
Incorrect
Incorrect
-
Question 9 of 15
9. Question
Contract Giver is not responsible for the reviewing and assessing the records and the results related to the outsourced activities.
Correct
GMP reference is PE 009-15, Part I, Chapter 7, Outsourced activities, clause 7.5 “The Contract Giver should be responsible for reviewing and assessing the records and the results related to the outsourced activities. He/she should also ensure, either by himself/herself, or based on the confirmation of the Contract Acceptor’s Authorised Person, that all products and materials delivered to him/her by the Contract Acceptor have been processed in accordance with GMP and the Marketing Authorisation.”
Incorrect
Incorrect
-
Question 10 of 15
10. Question
In the case on investigational medicinal products:
Correct
GMP reference is PE 009-15, Part I, Chapter 8, Complaints and product recall, clause 8.24 “In the case of investigational medicinal products, all trial sites should be identified and the countries of destination should be indicated. In the case of an investigational medicinal product for which a marketing authorisation has been issued, the manufacturer of the investigational medicinal product should, in cooperation with the sponsor, inform the marketing authorisation holder of any quality defect that could be related to the authorised medicinal product.”
Incorrect
Incorrect
-
Question 11 of 15
11. Question
Out-of-Specification API batches:
Correct
GMP reference is PE 009-15, Part II, Production and In-Process Controls, clause 8.41 “Out-Of-Specification batches should not be blended with other batches for the purpose of meeting specifications. Each batch incorporated into the blend should have been manufactured using an established process and should have been individually tested and found to meet appropriate specifications prior to blending.”
Incorrect
Incorrect
-
Question 12 of 15
12. Question
Where a computerised system replaces a manual operation, there should be no resultant decrease in:
Correct
GMP reference is PE 009-15, Annex 11, Computerised Systems, Principle section “Where a computerised system replaces a manual operation, there should be no resultant decrease in product quality, product control or quality assurance. There should be no increase in the overall risk of the process.”
Incorrect
Incorrect
-
Question 13 of 15
13. Question
When a computerised system is used for recording certification and batch release:
Correct
GMP reference is PE 009-15, Annex 15, Qualification and Validation, General section “Data supporting qualification and/or validation studies which were obtained from sources outside of the manufacturers own programmes may be used provided that this approach has been justified and that there is adequate assurance that controls were in place throughout the acquisition of such data.”
Incorrect
Incorrect
-
Question 14 of 15
14. Question
Premises and equipment used for the manufacturing of investigational medicinal products:
Correct
GMP reference is PE 009-15, Annex 13, Manufacture of investigational medicinal products, clause 17 “Production processes for investigational medicinal products are not expected to be validated to the extent necessary for routine production but premises and equipment are expected to be qualified.”
Incorrect
Incorrect
-
Question 15 of 15
15. Question
Data supporting qualification and/or validation studies which were obtained from other sources than the manufacturers own programmes may be used:
Correct
GMP reference is PE 009-15, Annex 15, Qualification and Validation, General section “Data supporting qualification and/or validation studies which were obtained from sources outside of the manufacturers own programmes may be used provided that this approach has been justified and that there is adequate assurance that controls were in place throughout the acquisition of such data.”
Incorrect
Incorrect
Leaderboard: PIC/S GMP Quiz 2022
Pos. | Name | Entered on | Points | Result |
---|---|---|---|---|
Table is loading | ||||
No data available | ||||